Product
Flu Pandemic mRNA
1 clinical trial
2 indications
Indication
InfluenzaIndication
HumanClinical trial
A Phase 1/2, Randomized, Observer-blind, Dose-finding/Dose-confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the mRNA-based Investigational Pandemic H5 Influenza Vaccine Candidate Administered in Healthy Younger and Older AdultsStatus: Recruiting, Estimated PCD: 2024-08-21